Fumoy,
It has been a long time between drinks for many small cap stem cell companies - but like the tide these things change. Cynata has brilliant timing in this regard.
There will be a lot of people and brokers running there ruler over cyp thinking what added value could this company have to an existing stem cell company and for that matter specific treatment.
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.035(23.3%) |
Mkt cap ! $41.80M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 18.5¢ | 15.5¢ | $264.5K | 1.513M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23722 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 8078 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |